Table of Contents
Autism spectrum disorder (ASD) includes many syndromes that can range in severity from the social awkwardness and narrow interests to severe communication and intellectual disabilities. There is a growing demand for cost efficient tests that can help physicians diagnose and monitor chronic diseases such autism. There is therefore a market opportunity for highly sensitive, specific and cost effective screening tests for early diagnosis. Novel Autism Diagnostics examines selected autism test innovations that have emerged.
Novel Autism Diagnostics outlines many of the current approaches to autism testing, including molecular testing, pre-disposition screening, targeted sequencing-based testing, next-generation sequencing with modeling, genetic risk assessment / testing, cloud platform approaches, microarrays, end-to-end sequencing, gene variants, and blood-based genetic testing. The report looks at the companies behind these testing approaches as well.
The competitors discussed within the company profiles include Asuragen, Google Genomics, Illumina, and LabCorp.
The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This report studies the life science instruments and reagents market over the forecast period of 2017 to 2023. The life science instruments and reagents market is expected to grow at a high single digit ...
According to Stratistics MRC, the Global Next Generation Sequencing market is estimated at $3.41 billion in 2015 and is expected to reach $13.50 billion by 2022 growing at a CAGR of 21.73% from 2015 to ...
Next generation sequencing, also known as high-throughput sequencing, is a DNA sequencing technology that has revolutionized genomic research. Due to its ability to sequence DNA, NGS technologies have ...